KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Return on Equity (2020 - 2025)

GoodRx Holdings' Return on Equity history spans 6 years, with the latest figure at 0.05% for Q4 2025.

  • For Q4 2025, Return on Equity rose 3.0% year-over-year to 0.05%; the TTM value through Dec 2025 reached 0.05%, up 3.0%, while the annual FY2025 figure was 0.05%, 2.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.05% at GoodRx Holdings, down from 0.05% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.05% in Q2 2025 and bottomed at 0.44% in Q1 2021.
  • The 5-year median for Return on Equity is 0.02% (2024), against an average of 0.07%.
  • The largest annual shift saw Return on Equity plummeted -33bps in 2021 before it soared 42bps in 2022.
  • A 5-year view of Return on Equity shows it stood at 0.03% in 2021, then plummeted by -36bps to 0.04% in 2022, then surged by 74bps to 0.01% in 2023, then skyrocketed by 314bps to 0.02% in 2024, then soared by 117bps to 0.05% in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Return on Equity are 0.05% (Q4 2025), 0.05% (Q3 2025), and 0.05% (Q2 2025).